China (Mainland)
Premiumsupplier 
Erlotinib hydrochloride CAS NO.183319-69-9
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,
- Product Details
Keywords
- Erlotinib hydrochloride
- 183319-69-9
- C22H24ClN3O4
Quick Details
- ProName: Erlotinib hydrochloride
- CasNo: 183319-69-9
- Molecular Formula: C22H24ClN3O4
- Appearance: White or off-white Solid
- Application: Organic synthesis
- DeliveryTime: 20day
- PackAge: According to the demand of customer
- Port: shanghai
- ProductionCapacity: 20 Metric Ton/Month
- Purity: 99%
- Storage: Sealed, dry, microtherm , avoid light ...
- Transportation: by air or by sea
- LimitNum: 1 Kilogram
- Grade: Industrial Grade,Pharma Grade,Electron...
Superiority
high quality
Details
| Erlotinib hydrochloride Basic information |
| Product Name: | Erlotinib hydrochloride |
| Synonyms: | ERLOTINIB HCL;ERLOTINIB HCL SALT;ERLOTINIB HCL SALT :TARCEVA;Erlotinib, Hydrochloride Salt;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva; N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine;Tarceva Hydrochloride See E625000 |
| CAS: | 183319-69-9 |
| MF: | C22H24ClN3O4 |
| MW: | 429.9 |
| EINECS: | |
| Product Categories: | API;Molecular Targeted Antineoplastic;Heterocyclic Compounds;anti-neoplastic;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Tarceva;Antineoplastic;Anti-cancer&immunity |
| Mol File: | 183319-69-9.mol |
|
|
|
| Erlotinib hydrochloride Chemical Properties |
| mp | 223-225°C |
| storage temp. | -20°C Freezer |
| CAS DataBase Reference | 183319-69-9(CAS DataBase Reference) |
| Safety Information |
| Erlotinib hydrochloride Usage And Synthesis |
| Chemical Properties | Off-White Solid |
| Usage | Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic |
| Usage | Erlotinib HCl is an HER1/EGFR inhibitor with IC50 of 2 nM. |
| Usage | Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Phase 3. |
| Erlotinib hydrochloride Preparation Products And Raw materials |